The Software Works. The Workflow Doesn’t.
A common pattern in risk adjustment implementations: the software demos well, passes the proof-of-concept, and goes live successfully. The AI identifies diagnoses accurately. The MEAT validation works. The evidence trails are generated. Six months later, coder productivity hasn’t improved, error rates haven’t dropped, and the team is frustrated. The software works. The workflow around it doesn’t.
The bottleneck is rarely the technology itself. It’s the points where human process and automated capability intersect. The software can validate MEAT evidence in seconds, but if the coder’s workflow requires three system switches and two manual data lookups before reaching the validation screen, the time savings evaporate in navigation overhead. The AI can recommend deletions, but if the QA workflow doesn’t include a deletion review step, the recommendations accumulate in a queue nobody checks.
Three Workflow Bottlenecks That Kill Software ROI
The first is the chart access bottleneck. The software needs clinical documentation to process. If charts arrive in batch queues with 24-to-48-hour delays from EHR systems, coders wait for input the software could process in real time. The AI sits idle while the data pipeline drips. Plans that invest in near-real-time EHR integration eliminate this bottleneck and unlock the processing speed the software was designed to deliver.
The second is the provider query bottleneck. When the software identifies documentation gaps, those gaps need provider clarification. If the query workflow routes through a manual process (generate query, send via fax or email, wait for response, manually update the coding record), the gap between identification and resolution stretches from hours to weeks. During that interval, the code either waits (creating a backlog) or ships without the clarification (creating audit risk). Automated query routing with EHR-integrated response tracking compresses this interval.
The third is the QA bottleneck. Software that produces evidence-validated recommendations still requires human quality review. If QA capacity isn’t scaled to match the increased throughput the AI enables, a bottleneck forms at the QA step. Coders process more charts. QA reviews the same number. The excess waits in queue or bypasses review entirely. Either outcome defeats the purpose of the quality-focused technology.
Diagnosing Before Blaming the Software
Plans dissatisfied with their risk adjustment software performance should map the end-to-end workflow before concluding the technology is inadequate. Measure the time between chart availability and coder access. Measure query-to-resolution cycle times. Measure QA throughput relative to coding throughput. The bottleneck that’s suppressing software ROI is usually visible in these measurements, and it’s usually a workflow problem the software can’t solve alone.
Workflow First, Software Second
Any risk adjustment software investment should include a workflow optimization assessment alongside the technology evaluation. The best AI in the market, deployed into a workflow with access delays, manual query processes, and undersized QA capacity, will underperform a good AI deployed into a workflow designed for its throughput. Plans that fix the workflow and the software simultaneously get the ROI the technology was designed to deliver.
